Cognitive Behavioral Affective Therapy for Anger
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach called Cognitive Behavioral Affective Therapy (CBAT) to help people manage disruptive anger. Researchers aim to determine if CBAT can effectively reduce anger, particularly when it becomes harmful or leads to risky health issues like high blood pressure. Participants will receive either CBAT or general emotion education to compare results. This trial suits individuals in the U.S. with ongoing anger issues who are not currently receiving treatment. As an unphased trial, it offers a unique opportunity to explore innovative therapy methods that could significantly improve emotional well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, you cannot be undergoing any psychological or psychiatric treatment to participate.
What prior data suggests that Cognitive Behavioral Affective Therapy is safe for anger management?
Research shows that Cognitive Behavioral Affective Therapy (CBAT) is generally safe. Studies on similar therapies, such as Cognitive Behavioral Therapy (CBT) for anger, have found them to be well-tolerated. Participants often experience improvements in self-control and problem-solving without serious side effects.
CBAT has been tested in various groups, including those with substance use issues and long-term pain, and these studies have not reported major negative effects. This suggests that CBAT is safe for managing anger and related issues.
CBAT's strong safety record in other areas indicates it is likely safe for anger management. However, as with any treatment, participants should monitor their feelings and report any concerns to the study team.12345Why are researchers excited about this trial?
Cognitive Behavioral Affective Therapy (CBAT) is unique because it combines traditional cognitive behavioral therapy techniques with a focus on emotional regulation specifically for managing anger. While most treatments for anger, such as anger management classes and standard cognitive behavioral therapy, focus on behavior modification and cognitive restructuring, CBAT emphasizes understanding and managing the emotional processes that lead to anger. Researchers are excited about CBAT because it targets the root emotional triggers of anger, potentially offering a more comprehensive and effective approach to treatment. This focus on emotional regulation could lead to longer-lasting improvements in managing anger compared to existing methods.
What evidence suggests that Cognitive Behavioral Affective Therapy might be an effective treatment for anger?
Research has shown that Cognitive Behavioral Affective Therapy (CBAT), which participants in this trial may receive, can effectively manage anger. Studies have found that methods like CBAT greatly reduce feelings of anger. For instance, one study reported a significant drop in anger levels among people who completed this therapy. Another review highlighted that cognitive-behavioral therapy (CBT) for anger management can lower the risk of violent behavior by 28%. This suggests that CBAT could be a promising choice for those seeking to control and reduce their anger.678910
Are You a Good Fit for This Trial?
This trial is for individuals who struggle with excessive anger, such as those with Intermittent Explosive Disorder or related conditions. It's aimed at people whose anger leads to distress and problems in daily life. Participants should be interested in exploring therapy to manage their emotions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Cognitive Behavioral Affective Therapy (CBAT) or Emotional Education (EE) through video sessions over 4 weeks
Interim Period
Participants have a 3-week interim period to reflect and implement learned techniques
Follow-up
Participants are monitored for safety and effectiveness after treatment, including a final follow-up session
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Affective Therapy
Cognitive Behavioral Affective Therapy is already approved in United States, European Union, Canada for the following indications:
- Intermittent Explosive Disorder
- Anxiety Disorders
- Chronic Pain Management
- Chemical Dependence
- Intermittent Explosive Disorder
- Anxiety Disorders
- Mood Disorders
- Intermittent Explosive Disorder
- Anxiety Disorders
- Chronic Pain Management
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas at San Antonio
Lead Sponsor